Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greenline Clinical Research is a private, active contract research organization focused on clinical development support for biotech sponsors. The company provides full-service CRO capabilities across trial phases, including regulatory and medical consulting, protocol design, site selection, clinical operations, biometrics, pharmacovigilance, laboratory services, and decentralized trial support. Its therapeutic experience spans oncology and immuno-oncology, infectious diseases and vaccines, neurology, and rare diseases. The organization also supports advanced therapeutic programs such as cell and gene therapies, RNA-based therapeutics, antibody-drug conjugates, microbiome programs, and radiopharmaceuticals. Greenline appears to be a services company rather than a drug developer, so it does not have a proprietary therapeutic pipeline in the usual biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Line.